Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I production.

Nature communications·2026
Same author

Structure Merging Approach Leads to New Dual Potent and Selective USP25/USP28 Inhibitors.

Journal of medicinal chemistry·2026
Same author

Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular Degraders.

Journal of medicinal chemistry·2025
Same author

High-Throughput Synthesis and Screening of a Cyanimide Library Identifies Selective Inhibitors of ISG15-Specific Protease mUSP18.

Angewandte Chemie (International ed. in English)·2025
Same author

Membrane Contact Sites in Proteostasis and ER Stress Response.

Contact (Thousand Oaks (Ventura County, Calif.))·2025
Same author

Advancing the Exploration of the Ubiquitin-like Protein FUBI with Synthetic Chemical Tools.

Chembiochem : a European journal of chemical biology·2025
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jul 19, 2025

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

341

Plate-Based Screening for DUB Inhibitors.

Stephan Scherpe1, Aysegul Sapmaz1, Monique P C Mulder2

  • 1Department of Cell and Chemical Biology, Leiden University Medical Centre, Leiden, The Netherlands.

Methods in Molecular Biology (Clifton, N.J.)
|August 9, 2023
PubMed
Summary
This summary is machine-generated.

Researchers developed a new assay to screen for small-molecule inhibitors targeting deubiquitinating enzymes (DUBs). This tool aids in developing drugs for diseases linked to imbalanced ubiquitination.

Keywords:
DUBsDeubiquitinating enzymesInhibitorsScreeningUbiquitin

More Related Videos

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K

Related Experiment Videos

Last Updated: Jul 19, 2025

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

341
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Ubiquitin (Ub) is a crucial post-translational modifier regulating numerous cellular processes.
  • Dysregulated ubiquitination is implicated in various human diseases.
  • Deubiquitinating enzymes (DUBs), which remove ubiquitin, are recognized as significant therapeutic targets.

Purpose of the Study:

  • To develop and validate a robust assay for high-throughput screening of small-molecule inhibitors targeting DUBs.
  • To facilitate the discovery of novel therapeutic agents for diseases associated with aberrant ubiquitination.

Main Methods:

  • Development of a novel assay platform for DUB activity assessment.
  • Implementation of small-molecule inhibitor screening protocols.
  • Assay validation for robustness and suitability for drug discovery.

Main Results:

  • A reliable assay for screening DUB inhibitors was successfully established.
  • The assay demonstrated suitability for identifying selective DUB-targeting compounds.
  • This platform has the potential to accelerate the development of DUB-based therapeutics.

Conclusions:

  • The developed assay is a valuable tool for identifying small-molecule inhibitors of DUBs.
  • This screening platform can significantly contribute to the development of targeted therapies for ubiquitination-related diseases.
  • Targeting DUBs represents a promising strategy for future drug development.